A5012434860- Health Systems, Economic Evaluations, Quality of Life
- Healthcare cost, quality, practices
- Healthcare Systems and Reforms
- Pharmaceutical Economics and Policy
- Healthcare Policy and Management
- Global Health Care Issues
- Global Public Health Policies and Epidemiology
- Multiple Myeloma Research and Treatments
- Dialysis and Renal Disease Management
- Chronic Myeloid Leukemia Treatments
- Health Policy Implementation Science
- Ethics in Clinical Research
- Global Maternal and Child Health
- HIV/AIDS Research and Interventions
- Health disparities and outcomes
- HIV/AIDS drug development and treatment
- Renal Diseases and Glomerulopathies
- Economic and Financial Impacts of Cancer
- Clinical practice guidelines implementation
- Retinal Imaging and Analysis
- Retinal Diseases and Treatments
- COVID-19 and healthcare impacts
- HIV/AIDS Impact and Responses
- Central Venous Catheters and Hemodialysis
- Myeloproliferative Neoplasms: Diagnosis and Treatment
National University of Singapore
2020-2024
National University Health System
2020-2024
University of the Philippines Manila
2021
Department of Health
2019-2020
Health Intervention and Technology Assessment Program
2020
There is growing interest globally in using real-world data (RWD) and evidence (RWE) for health technology assessment (HTA). Optimal collection, analysis, use of RWD/RWE to inform HTA requires a conceptual framework standardize processes ensure consistency. However, such currently lacking Asia, region that likely benefit from at least two reasons. First, there often limited Asian representation clinical trials unless specifically conducted populations, RWD may help fill the gap. Second, few...
Deliberative processes for health technology assessment (HTA) are intended to facilitate participatory decision making, using discussion and open dialogue between stakeholders. Increasing attention is being given deliberative processes, but guidance lacking those who wish design or use them. Health Technology Assessment International (HTAi) ISPOR-The Professional Society Economics Outcomes Research initiated a joint Task Force address this gap.The consisted of 15 members with different...
Deliberative processes for health technology assessment (HTA) are intended to facilitate participatory decision making, using discussion and open dialogue between stakeholders. Increasing attention is being given deliberative processes, but guidance lacking those who wish design or use them. Health Technology Assessment International (HTAi) ISPOR-The Professional Society Economics Outcomes Research initiated a joint Task Force address this gap.The consisted of fifteen members with different...
The Philippines has the highest cumulative COVID-19 cases and deaths in Western-Pacific. To explore broader health impacts of pandemic, we assessed magnitude duration changes hospital admissions for 12 high-burden diseases utilization five common procedures by lockdown stringency, level, equity patient access.
Globally, there is increasing interest in the use of real-world data (RWD) and evidence (RWE) to inform health technology assessment (HTA) reimbursement decision-making. Using current practices case studies shared by eleven systems Asia, a non-binding guidance that seeks align for generating using RWD/RWE decision-making Asia was developed REAL World Data In ASia HEalth Technology Assessment Reimbursement (REALISE) Working Group, addressing gap needs among HTA users generators.The document...
Abstract This paper explores the characteristics of health technology assessment (HTA) systems and practices in Asia. Representatives from nine countries were surveyed to understand each step HTA pathway. The analysis finds that although there are similarities processes its application inform decision making, is variation number topics assessed stakeholders involved process. There limited availability resources technical capacity adopt different means overcome these challenges by accepting...
Expensive treatments such as renal dialysis are a challenge for countries aiming universal coverage. <b>Yot Teerawattananon and colleagues</b> set out systematic approach to ensuring it is affordable
Abstract—Achievement of universal health coverage requires better allocative efficiency in systems. Countries like the Philippines, however, do not have quality local data for these decisions. We present a method that applies existing global data, e.g., Global Burden Disease and Control Priorities project, into creating priority list diseases interventions may be useful providing rational plan expanding services paid by public financing. In context this refers to Department Health vertical...
Kidney failure patients in the Philippines have free choice on their kidney replacement therapy (KRT), with a majority choosing haemodialysis (HD) over peritoneal dialysis (PD) and transplantation despite inadequate coverage of HD. Although national health insurance is limited, KRT remains to be one top benefits pay-outs country. The study aims identify most cost-effective policy strategy for financing Philippines, context universal healthcare policy.A Markov model was developed estimate...
Abstract Multiple myeloma, a hematological malignancy, imposes significant financial burden on healthcare systems. Health technology assessments (HTA) and economic evaluations play vital roles in reimbursement decisions cost containment. This study aimed to explore utilization patterns costs among myeloma patients Singapore through retrospective analysis of 605 treated at two cancer centers. Data encompassing demographics, treatment utilization, billing were extracted from electronic...
Abstract Objectives The rising costs of drugs have necessitated the exploration innovative payment methods in healthcare systems. Risk-sharing agreements (RSAs) been implemented many countries as a value-based mechanism to manage uncertainty associated with expensive technologies. This study aimed investigate stakeholder perspectives on Singaporean context, providing insights for future directions health technology assessment and financing. Methods descriptive qualitative inquiry involved...
<ns4:p>The World Health Organization (WHO) launched the OneHealth Tool (OHT) to help low and middle income countries develop their capacities for sector-wide priority setting. In 2016, we sought use OHT aid Philippine Insurance Corporation (PHIC), national health insurer of Philippines, in decisions expand benefit packages using cost-effectiveness analyses. With technical support from WHO, convened planning officers Department (DOH) (PHIC) conduct generalized cost-effective analyses (GCEA)...
The World Health Organization (WHO) launched the OneHealth Tool (OHT) to help low and middle income countries develop their capacities for sector-wide priority setting. In 2016, we sought use OHT aid Philippine Insurance Corporation (PHIC), national health insurer of Philippines, in decisions expand benefit packages using cost-effectiveness analyses. With technical support from WHO, convened planning officers Department (DOH) (PHIC) conduct generalized cost-effective analyses (GCEA) selected...
This study aimed to assess the cost-effectiveness of two regimens regarded as standard care for treatment newly diagnosed, transplant-ineligible multiple myeloma in Singapore: (1) daratumumab, lenalidomide, and dexamethasone (2) bortezomib, dexamethasone. Additionally, it explore potential strategies manage decision uncertainty mitigate financial risk. A analysis from healthcare system perspective was conducted using a partitioned survival model estimate lifetime costs quality-adjusted life...
Abstract Objectives Health technology assessment (HTA) guidelines are intended to support the successful implementation of HTA by enhancing consistency and transparency in concepts, methods, processes, use, thereby legitimacy decision-making process. This report lays out good practices practical recommendations for developing or updating ensure implementation. Methods The task force was established 2022 comprised experts academics from various geographical regions, each with substantial...
<h3>Background</h3> The Philippines is broadening its coverage for primary healthcare by increasing the number of services included in PhilHealth benefit package, expanding to more members and accrediting providers. <h3>Objectives</h3> main objective describe process scoping a care requiring identification disease priorities their corresponding interventions. <h3>Methods</h3> criteria used identify target diseases were epidemiologic fit, cost-efficiency, feasibility delivery, complete cycle...
Abstract Background: Preventing mother-to-child transmission of human immunodeficiency virus is important due to the impact disease women and their children’s health. Established guidelines have recommended strengthening ability detect treat HIV as early possible. This study attempts explore cost-effective PMTCT interventions in a low incidence, low-middle income setting such Philippines that can be replicated other similar country settings. Methods: The utilized model-based...